 |
|
BCG Immunoprophylaxis of Recurrent Herpes Progenitalis
Stanley M. Bierman, MD
Arch Dermatol. 1976;112(10):1410-1415.
Abstract
• Thirty-eight patients with severe, recurrent herpes progenitalis were treated by immunoprophylaxis with repeated BCG inoculations. Results of the study demonstrated no significant prophylactic benefit of BCG when contrasted to other homologous or heterologous antigens or to control patients receiving placebos. Caution is warranted in the use of homologous vaccines from Germany because theoretically, tumor growth might be enhanced by immunologic means, although the vaccine apparently has no intrinsic oncogenic qualities.
(Arch Dermatol 112:1410-1415, 1976)
Author Affiliations
From the Divisions of Dermatology, UCLA Center for the Health Sciences and the Veterans Administration Wadsworth Hospital Center, Los Angeles.
Footnotes
Accepted for publication Jan 23, 1976.
Reprint requests to Century City Medical Plaza, 2080 Century Park East, Los Angeles, CA 90067 (Dr Bierman).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Recurrent Genital Herpes Simplex Infection: A Trivial Disorder
Bierman
Arch Dermatol 1985;121:513-517.
ABSTRACT
Genital Herpes Simplex Virus Infections: Current Concepts in Diagnosis, Therapy, and Prevention
LAWRENCE and HOLMES
ANN INTERN MED 1983;98:973-983.
ABSTRACT
Sabin's Poliomyelitis Vaccine in Recurrent Herpes Simplex-Reply
Bierman
Arch Dermatol 1978;114:1094-1095.
ABSTRACT
|
